Interview With Seth Berkley, CEO Of Gavi, The Vaccine Alliance 11/06/2019 William New A medical doctor and epidemiologist, Dr Seth Berkley joined Gavi, the Vaccine Alliance, as its CEO in August 2011. Under his leadership, Gavi reached the milestone in 2015 of more than half a billion children vaccinated in the world’s 73 poorest countries. In the same year, Berkley led Gavi to its second successful replenishment, raising […] Continue reading -> New Gavi Partnership: Deploying Biometric Technology To Expand Child Vaccine Coverage 07/06/2019 Divya Schlesinger A major agreement has been signed between Gavi, the Vaccine Alliance, and two private sector partners to deploy a new form of biometric fingerprint technology to give children – who may not even have a birth certificate – a complete medical record in order to track critical childhood vaccines. Image Credits: Simprints, Simprints . Continue reading -> WHA Strengthens Benefit Sharing System For Pandemic Flu Vaccine Development 03/06/2019 Catherine Saez In a little-publicised move, the WHA last week agreed to close a critical loophole in the WHO Pandemic Influenza Preparedness (PIP) Framework that could have allowed commercial vaccine manufacturers to indirectly make use of biological information about flu strains from another country – without providing that country with any benefits from the vaccines or antivirals […] Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> New Plan For Ebola Outbreak Response To Ensure Safety Of Respondents 28/05/2019 Catherine Saez There has been a dramatic increase in security incidents around the epicentre of the Ebola epidemic in the Democratic Republic of the Congo (DRC), but a sharp decrease in hospital transmissions, increased vaccinations, and new measures to safeguard response teams, are positive signs, WHO officials told reporters today in a briefing. Image Credits: WHO/L.Mackenzie, Catherine […] Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
New Gavi Partnership: Deploying Biometric Technology To Expand Child Vaccine Coverage 07/06/2019 Divya Schlesinger A major agreement has been signed between Gavi, the Vaccine Alliance, and two private sector partners to deploy a new form of biometric fingerprint technology to give children – who may not even have a birth certificate – a complete medical record in order to track critical childhood vaccines. Image Credits: Simprints, Simprints . Continue reading -> WHA Strengthens Benefit Sharing System For Pandemic Flu Vaccine Development 03/06/2019 Catherine Saez In a little-publicised move, the WHA last week agreed to close a critical loophole in the WHO Pandemic Influenza Preparedness (PIP) Framework that could have allowed commercial vaccine manufacturers to indirectly make use of biological information about flu strains from another country – without providing that country with any benefits from the vaccines or antivirals […] Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> New Plan For Ebola Outbreak Response To Ensure Safety Of Respondents 28/05/2019 Catherine Saez There has been a dramatic increase in security incidents around the epicentre of the Ebola epidemic in the Democratic Republic of the Congo (DRC), but a sharp decrease in hospital transmissions, increased vaccinations, and new measures to safeguard response teams, are positive signs, WHO officials told reporters today in a briefing. Image Credits: WHO/L.Mackenzie, Catherine […] Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
WHA Strengthens Benefit Sharing System For Pandemic Flu Vaccine Development 03/06/2019 Catherine Saez In a little-publicised move, the WHA last week agreed to close a critical loophole in the WHO Pandemic Influenza Preparedness (PIP) Framework that could have allowed commercial vaccine manufacturers to indirectly make use of biological information about flu strains from another country – without providing that country with any benefits from the vaccines or antivirals […] Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> New Plan For Ebola Outbreak Response To Ensure Safety Of Respondents 28/05/2019 Catherine Saez There has been a dramatic increase in security incidents around the epicentre of the Ebola epidemic in the Democratic Republic of the Congo (DRC), but a sharp decrease in hospital transmissions, increased vaccinations, and new measures to safeguard response teams, are positive signs, WHO officials told reporters today in a briefing. Image Credits: WHO/L.Mackenzie, Catherine […] Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> New Plan For Ebola Outbreak Response To Ensure Safety Of Respondents 28/05/2019 Catherine Saez There has been a dramatic increase in security incidents around the epicentre of the Ebola epidemic in the Democratic Republic of the Congo (DRC), but a sharp decrease in hospital transmissions, increased vaccinations, and new measures to safeguard response teams, are positive signs, WHO officials told reporters today in a briefing. Image Credits: WHO/L.Mackenzie, Catherine […] Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> New Plan For Ebola Outbreak Response To Ensure Safety Of Respondents 28/05/2019 Catherine Saez There has been a dramatic increase in security incidents around the epicentre of the Ebola epidemic in the Democratic Republic of the Congo (DRC), but a sharp decrease in hospital transmissions, increased vaccinations, and new measures to safeguard response teams, are positive signs, WHO officials told reporters today in a briefing. Image Credits: WHO/L.Mackenzie, Catherine […] Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
New Plan For Ebola Outbreak Response To Ensure Safety Of Respondents 28/05/2019 Catherine Saez There has been a dramatic increase in security incidents around the epicentre of the Ebola epidemic in the Democratic Republic of the Congo (DRC), but a sharp decrease in hospital transmissions, increased vaccinations, and new measures to safeguard response teams, are positive signs, WHO officials told reporters today in a briefing. Image Credits: WHO/L.Mackenzie, Catherine […] Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo 27/05/2019 Editorial team [Gavi, the Vaccine Alliance, Press Release] Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges Geneva / Goma 27 May 2019 – More than 800,000 people will be immunised against cholera in North Kivu in the Eastern part of the Democratic Republic of the Congo (DRC) following the launch […] Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts
Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Posts navigation Older postsNewer posts